German Cockroach (Bla g 5) IgE

If you have asthma or year-round nasal symptoms and live in an urban or older building, German cockroach exposure may be doing more than you realize. This blood test looks at one specific cockroach protein that is among the top immune targets in cockroach-allergic people, especially in U.S. inner-city cohorts where it shows up in roughly 37% to 58% of sensitized patients.

A standard cockroach skin or extract test can tell you that your body recognizes cockroach in general. Component-level testing like this one pinpoints which specific cockroach molecule your immune system is reacting to, which helps separate real cockroach allergy from look-alike reactions caused by dust mite cross-reactivity.

What This Test Is Actually Measuring

Bla g 5 (Blattella germanica allergen 5) is a glutathione S-transferase, a small enzyme made inside the German cockroach. When you breathe in cockroach particles from dust, your immune system can build IgE antibodies (a class of antibody your body uses for allergic responses) that recognize this protein. This test measures the amount of those Bla g 5-specific IgE antibodies circulating in your blood.

This is a component-resolved diagnostic, meaning it isolates one molecule rather than testing against a mixture of cockroach proteins. Bla g 5 is one of several known cockroach allergens (Bla g 1, 2, 4, 5, 7, 9, and others), and patterns of which proteins a person reacts to are highly individual. Together with Bla g 2, it is often one of the largest contributors to total cockroach IgE in U.S. patients.

Where This Marker Sits in Clinical Use

Component IgE testing for cockroach is a research-grade and specialty allergy tool. There are no standardized clinical cutpoints that say one number is safe and another is dangerous. Results are best read as part of a panel, alongside other cockroach components and your clinical history, rather than as a single threshold to clear.

Asthma Connection

Cockroach sensitization is one of the strongest indoor allergen drivers of asthma in urban environments. Reviews report that 40% to 60% of asthma patients in urban and inner-city areas carry IgE antibodies to cockroach allergens. Within that group, Bla g 5 is often one of the dominant IgE targets, and some reports describe Bla g 5 IgE in up to about 70% of asthmatic cockroach-allergic patients in certain populations.

In children with mild-to-moderate asthma, cockroach allergen-specific T cell responses (a separate arm of the immune system) and IgE patterns are unique to each child. Higher Bla g IgE generally tracks with stronger type 2 immune responses, the kind of inflammation that fuels allergic asthma. In a study comparing asthmatic and rhinitis-only subjects, the asthmatic group showed larger and differently targeted T cell responses to German cockroach allergens, with Bla g 5 standing out as a dominant antigen.

Allergic Rhinitis and Atopic Disease

Bla g 5 sensitization shows up in allergic rhinitis as well, though the immune patterns are not identical to asthma. People with cockroach-driven rhinitis tend to have different dominant T cell antigens than those with asthma, which is one reason a single number does not fully predict which condition will develop.

In atopic dermatitis cohorts, component testing across multiple allergens has linked higher levels of specific IgE to greater severity of skin disease, asthma, and rhinitis. Bla g 5 is one of the cockroach components included in those broad multiplex panels, though it is rarely the standout driver in eczema-focused populations.

Geographic and Population Differences

How meaningful a Bla g 5 result is depends partly on where you live. In U.S. and several Asian cohorts, Bla g 5 is consistently among the more frequently recognized cockroach components. In a Central European allergy clinic population of 1,766 patients, true sensitization to any cockroach molecule (Bla g 1, 2, or 5) was found in only 0.6% of patients and was almost always co-sensitization with other allergens.

Sources: Satinover 2005, Panzner 2018, Sun 2010.

What this means for you: a positive Bla g 5 result is more likely to reflect genuine cockroach sensitization than a positive cockroach extract test alone, because component testing bypasses some of the dust mite cross-reactivity problem.

Cross-Reactivity With Dust Mites and Parasites

Glutathione S-transferases are found in many organisms, which creates the potential for cross-reactivity. In tropical settings, IgE to Ascaris (a roundworm) glutathione S-transferase is correlated with Bla g 5 IgE, though the cross-reactivity is limited enough that Bla g 5 still helps pinpoint true cockroach allergy versus parasite-driven responses.

This is one of the practical reasons component testing exists. A standard cockroach extract test can light up because of dust mite or parasite cross-reactivity, while testing Bla g 5 directly gives you a cleaner read on cockroach itself.

When Results Can Be Misleading

A few factors can throw off how you interpret a single Bla g 5 IgE result:

• Polysensitization patterns: patients often have IgE to multiple cockroach components, and a low or absent Bla g 5 does not rule out clinically meaningful cockroach allergy if other components like Bla g 2 are elevated.
• Geographic context: in regions where true cockroach component sensitization is rare, an isolated positive may reflect cross-reactivity from other allergens rather than primary cockroach allergy.
• Recent allergen exposure: specific IgE levels can drift with ongoing or recent exposure, so a one-time value is a snapshot, not a fixed trait.
• Assay differences: different labs and platforms (ImmunoCAP, multiplex microarrays) may not produce interchangeable numbers, so trending matters more on the same platform.

Why One Reading Is Not Enough

Allergen-specific IgE is a moving target. Levels respond to exposure intensity, season, and immune treatment, and a single value rarely tells the full story. The most useful approach is to get a baseline now, then retest in 3 to 6 months if you change your environment or start treatment, and at least annually thereafter while you remain symptomatic.

Trending matters even more for Bla g 5 because this marker sits inside a research and specialty context with no universally agreed cutpoints. Your own trajectory becomes your reference range. A rising number alongside worsening asthma symptoms is meaningful, even if the absolute value would be ambiguous on its own.

What to Do With an Unexpected Result

A positive Bla g 5 IgE that lines up with your symptoms is a reason to take cockroach exposure seriously, not a final diagnosis. The decision pathway typically looks like this:

• Pair it with companion testing: look at other cockroach components (Bla g 1, 2, 4, 9), total IgE, and dust mite components to map your full sensitization profile.
• Confirm clinical relevance: see a board-certified allergist for skin prick testing and, in selected cases, nasal allergen challenge, which remains the strongest confirmation of true clinical reactivity.
• Address the environment: integrated pest management at home, sealing entry points, and reducing kitchen and bedroom dust reservoirs are the foundation of cockroach allergy care.
• Discuss immunotherapy and biologics: if cockroach is a confirmed driver of asthma or rhinitis, an allergist can weigh subcutaneous immunotherapy or anti-IgE biologic options based on your overall allergen profile.

A negative or low Bla g 5 does not close the door on cockroach allergy. Because sensitization patterns are individualized, you may still react to Bla g 2 or another component. A complete cockroach component panel is the better test if cockroach allergy is suspected.